Treatment Outcome of Elastomeric and Nickel-Titanium Separators in Tooth Separation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-25
Sponsor3D-Aligners

About this trial

Patients seeking fixed orthodontic treatment that requires band placement will be enrolled in this study. This trial aims to compare the efficiency of rectangular cross-section nickel-titanium separators with elastomeric separators in creating sufficient interdental space for orthodontic band placement. In addition, the impact of both separator types on pain perception and gingival health during a 3-day placement period will be evaluated. Participants will be allocated to two groups in a split-mouth design. On the experimental side, nickel-titanium separators will be used, while elastomeric separators will be used as the control on the other side. Outcomes will include separation efficacy, pain perception over time, gingival inflammation, analgesic consumption, and separator loss.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Class I skeletal and dental malocclusion.

No history of previous orthodontic treatment.

All permanent teeth in both arches, except third molars.

Good oral hygiene and periodontal health.

Disqualifiers

Patients presenting with restorations or carious lesions on the proximal surfaces of the first or second molars or the second premolars.

Patients with uncontrolled gingival or periodontal inflammation.

Patients with a history of previous orthodontic treatment.

Patients are skeletally classified as Class II or Class III.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Elastomeric separators

    Other intervention

    application of the elastomeric separators before application of the orthodontic bands on the first molars

  • Nickel-Titanium separators

    Other intervention

    application of the Nickel-Titanium separators before application of the orthodontic bands on the first molars

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Nickle-titanium groupExperimental treatment 1 intervention
Group B: elastomeric groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain Perception

Pain perception will be assessed using a Visual Analogue Scale (VAS) and a standardized questionnaire. Patients will receive a pain perception worksheet containing a 100 mm horizontal VAS line for each side of the mouth. The scale will range from "no pain" to "worst pain imaginable" and will be completed during rest, biting, chewing, work/school activities, and sleep

Time frame
At 4, 24, 48, and 72 hours after separator placement.
2

Separation efficacy

Interdental separation will be measured at the time of separator removal using a feeler gauge. A separation greater than 0.16 mm will be considered sufficient for band placement, while a separation of less than 0.16 mm will be considered insufficient.

Time frame
At 72 hours after separator placement, at the time of separator removal
3

Gingival inflammation

Gingival inflammation will be assessed using the Löe Gingival Index. Scores will range from Grade 0 (healthy gingiva) to Grade 3 (severe gingivitis with spontaneous bleeding and ulceration).

Time frame
At baseline, before separator placement, and immediately before separator removal, 72 hours after separator placement

Secondary outcomes

1

Analgesic usage

Participants may take ibuprofen (400 mg) as needed for pain relief. Analgesic consumption will be recorded using a standardized patient worksheet, including the time of intake, dosage, and the arch side associated with the pain.

Time frame
At 72 hours after separator placement.
2

Separator loss

Separator loss will be recorded clinically at the follow-up visit. A separator is considered lost if it was absent at the time of scheduled removal. Loss events are documented for each side separately.

Time frame
At 72 hours after separator placement.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: